Original Research
Accepted on 20 Dec 2024
DNA-loaded targeted nanoparticles as a safe platform to produce exogenous proteins in tumor B cells
Frontiers in Immunology
doi 10.3389/fimmu.2024.1509322
Volumes
41,296 Publications
Volume 15 - 2024
Review
Accepted on 20 Dec 2024
The role of ferroptosis in colorectal cancer and its potential synergy with immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1526749
Review
Accepted on 20 Dec 2024
Neutralizing antibody landscape of the non-polio Enteroviruses and future strategy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1524356
Original Research
Accepted on 20 Dec 2024
Evaluation of de novo donor specific antibodies after kidney transplantation in the era of donor-derived cell-free DNA
Frontiers in Immunology
doi 10.3389/fimmu.2024.1530065
Original Research
Accepted on 20 Dec 2024
Piloting an Automated Query and Scoring System to Facilitate APDS Patient Identification from Health Systems
Frontiers in Immunology
doi 10.3389/fimmu.2024.1508780
Original Research
Accepted on 20 Dec 2024
Erythropoietin supplementation induces dysbiosis of the gut microbiota and impacts mucosal immunity in a non-diseased mouse model
Frontiers in Immunology
doi 10.3389/fimmu.2024.1465410
Review
Accepted on 20 Dec 2024
Mitochondrial Dysfunction in Alzheimer's Disease: A Key Frontier for Future Targeted Therapies
Frontiers in Immunology
doi 10.3389/fimmu.2024.1484373
Original Research
Accepted on 20 Dec 2024
The impact of signaling pathways on the desmosome ultrastructure
Frontiers in Immunology
doi 10.3389/fimmu.2024.1497241
Original Research
Accepted on 20 Dec 2024
Multimodal data deep learning method for predicting symptomatic pneumonitis caused by lung cancer radiotherapy combined with immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1492399
Original Research
Accepted on 20 Dec 2024
Pan-cancer and experimental analyses reveal the immunotherapeutic significance of CST2 and its association with stomach adenocarcinoma proliferation and metastasis
Frontiers in Immunology
doi 10.3389/fimmu.2024.1466806
Original Research
Accepted on 20 Dec 2024
ESAT-6 protein suppresses allograft rejection by inducing CD4+Foxp3+ regulatory T cells through IkBa/cRel pathway
Frontiers in Immunology
doi 10.3389/fimmu.2024.1529226
Original Research
Accepted on 20 Dec 2024
Potential implications of Granzyme B in Keloids and Hypertrophic Scars through extracellular matrix remodeling and latent TGF-Beta activation
Frontiers in Immunology
doi 10.3389/fimmu.2024.1484462
Original Research
Accepted on 20 Dec 2024
Subtype-specific human endogenous retrovirus K102 envelope protein is a novel serum immunosuppressive biomarker of cancer
Frontiers in Immunology
doi 10.3389/fimmu.2024.1533740
Review
Accepted on 20 Dec 2024
Exploring effects of gut microbiota on tertiary lymphoid structure formation for tumor immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1518779
Correction
Accepted on 20 Dec 2024
Corrigendum: Identifying risk factors for secondary infection post-SARS-COV-2 infection in patients with severe and critical COVID-19
Frontiers in Immunology
doi 10.3389/fimmu.2024.1548101
Original Research
Accepted on 20 Dec 2024
Identification and validation of BATF as a prognostic biomarker and regulator of immune cell infiltration in acute myeloid leukemia
Frontiers in Immunology
doi 10.3389/fimmu.2024.1429855